Literature DB >> 9746134

Changes in the extracellular levels of glutamate and aspartate during ischemia and hypoglycemia. Effects of hypothermia.

F Boris-Möller1, T Wieloch.   

Abstract

Hypothermia (33 degrees C) dramatically diminishes ischemic but not hypoglycemic brain damage. The beneficial effects of hypothermia in ischemia have been partly attributed to a reduction in the ischemia-induced increase in synaptic levels of glutamate or aspartate. With the microdialysis technique, we studied the effects of hypothermia (33 degrees C) on the brain extracellular levels of glutamate and aspartate during hypoglycemia, ischemia, and their combination. In isoelectric hypoglycemia, striatal levels of glutamate and aspartate frequently show large transients of transmitter release occurring during both normothermia and hypothermia, whereas in the cortex levels of glutamate and aspartate are slightly lower during hypothermia compared with normothermia. In both regions studied, complete ischemia induced by i.v. KCl results in a progressive increase in glutamate and aspartate levels over time. In normoglycemic animals, hypothermia markedly attenuates the increase in glutamate and aspartate levels in the striatum but not in the cortex. Also in hypoglycemic animals, complete ischemia causes a progressive increase in the glutamate and aspartate levels. However, hypothermia affects only striatal glutamate levels. Since hypothermia protects both cortex and striatum against ischemic brain injury and not against hypoglycemic injury, presumably the protective effect of hypothermia is due to factors other than prevention of glutamate or aspartate overflow.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746134     DOI: 10.1007/s002210050461

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  5 in total

Review 1.  Medicinal chemistry of competitive kainate receptor antagonists.

Authors:  Ann M Larsen; Lennart Bunch
Journal:  ACS Chem Neurosci       Date:  2010-12-10       Impact factor: 4.418

Review 2.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

3.  Neurochemical monitoring of therapeutic effects in large human MCA infarction.

Authors:  C Berger; K Kiening; S Schwab
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

4.  The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury.

Authors:  Alexander Zlotnik; Boris Gurevich; Evgenia Cherniavsky; Sergei Tkachov; Angela Matuzani-Ruban; Avner Leon; Yoram Shapira; Vivian I Teichberg
Journal:  Neurochem Res       Date:  2007-12-14       Impact factor: 3.996

5.  Personalized approach in brain protection by hypothermia: individual changes in non-pathological and ischemia-related glutamate transport in brain nerve terminals.

Authors:  Artem Pastukhov; Natalia Krisanova; Vitalii Maksymenko; Tatiana Borisova
Journal:  EPMA J       Date:  2016-12-15       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.